Search by Drug Name or NDC

    NDC 63459-0177-14 SYNRIBO 3.5 mg/mL Details

    SYNRIBO 3.5 mg/mL

    SYNRIBO is a SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cephalon, LLC. The primary component is OMACETAXINE MEPESUCCINATE.

    Product Information

    NDC 63459-0177
    Product ID 63459-177_f68bb131-b4bd-4141-8f45-ff929ac7c225
    Associated GPIs 21700040102120
    GCN Sequence Number 070253
    GCN Sequence Number Description omacetaxine mepesuccinate VIAL 3.5 MG SUBCUT
    HIC3 V1F
    HIC3 Description ANTINEOPLASTICS,MISCELLANEOUS
    GCN 33734
    HICL Sequence Number 024243
    HICL Sequence Number Description OMACETAXINE MEPESUCCINATE
    Brand/Generic Brand
    Proprietary Name SYNRIBO
    Proprietary Name Suffix n/a
    Non-Proprietary Name Omacetaxine Mepesuccinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 3.5
    Active Ingredient Units mg/mL
    Substance Name OMACETAXINE MEPESUCCINATE
    Labeler Name Cephalon, LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA203585
    Listing Certified Through n/a

    Package

    NDC 63459-0177-14 (63459017714)

    NDC Package Code 63459-177-14
    Billing NDC 63459017714
    Package 1 VIAL, SINGLE-USE in 1 CARTON (63459-177-14) / 1 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2012-11-19
    NDC Exclude Flag N
    Pricing Information N/A